[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341256-105":59,"doc-detail-341256-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","optimizing-cancer-therapy-a-review-of-the-multifaceted-effects-of-metronomic-chemotherapy","Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy","","Metronomic chemotherapy (MCT) is reviewed as a regimen delivering continuous, low-dose chemotherapeutics without prolonged drug-free intervals, producing biological effects distinct from standard Maximum Tolerated Dose (MTD) therapy. Evidence from pre-clinical and clinical studies highlights lower toxicity, reduced risk of acquired therapeutic resistance, and improved cost-effectiveness. Emphasis is placed on MCT’s anti-angiogenesis actions, modulation of regulatory T cells, and promotion of anti-tumor immunity via dendritic cell maturation and cytotoxic T-cell expansion, including rationale for combination approaches and future development directions.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/optimizing-cancer-therapy-a-review-of-the-multifaceted-effects-of-metronomic-chemotherapy/341256/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/optimizing-cancer-therapy-a-review-of-the-multifaceted-effects-of-metronomic-chemotherapy/341256.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What distinguishes metronomic chemotherapy (MCT) from Maximum Tolerated Dose (MTD) therapy?","Question",{"text":113,"@type":114},"MCT uses continuous administration of chemotherapeutics at lower doses without prolonged drug-free periods, whereas MTD relies on the maximum dose tolerated without lethal harm, typically requiring rest intervals.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What main biological effects does MCT have according to the review?",{"text":118,"@type":114},"MCT is highlighted for anti-angiogenesis effects, stimulation of anti-angiogenic molecules, reduction of regulatory T-cell populations, and enhancement of anti-tumor immune responses through dendritic cell maturation and increased cytotoxic T-cells.",{"name":120,"@type":111,"acceptedAnswer":121},"How does MCT relate to therapeutic resistance and treatment outcomes?",{"text":122,"@type":114},"The review notes that MCT has a reduced likelihood of inducing acquired therapeutic resistance, helping address relapse that can occur with standard MTD approaches.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341256,1790193190,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":36,"preview_page_count":19,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","TYPE Review  \nPUBLISHED 15 May 2024  \nDOI 10.3389/fcell.2024.1369597  \nOPEN ACCESS  \nEDITED BY  \nEswar Shankar,  \nThe Ohio State University, United States  \nREVIEWED BY  \nBalaji Chandrasekaran,  \nTexas A and M University, United States Radha Vaddavalli,  \nThe Ohio State University, United States  \n*CORRESPONDENCE  \nAhmet Acar,  \n [acara@metu.edu.tr](acara@metu.edu.tr)  \n[M. Walid Qoron](M. Walid Qoron)ﬂ[eh](eh),  [walidq@yahoo.com](walidq@yahoo.com)[ ](walidq@yahoo.com)Sawsan Mohammed,  [sawsan@qu.edu.qa](sawsan@qu.edu.qa)  \nRECEIVED 12 January 2024  \nACCEPTED 29 April 2024  \nPUBLISHED 15 May 2024  \nCITATION  \nBasar OY, Mohammed S, Qoronﬂeh MW and Acar A (2024), Optimizing cancer therapy: areview of the multifaceted effects of metronomic chemotherapy.  \nFront. Cell Dev. Biol. 12:1369597 .  \ndoi: 10.3389/fcell.2024.1369597  \nCOPYRIGHT  \n© 2024 Basar, Mohammed, Qoronﬂeh and Acar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nOptimizing cancer therapy: areview of the multifaceted effects of metronomic chemotherapy  \nOyku Yagmur Basar 1, Sawsan Mohammed 2*, M. Walid Qoronﬂeh3* and Ahmet Acar 1*  \n1Department of Biological Sciences, Middle East Technical University, Ankara, Türkiye, 2Qatar University, QU Health, College of Medicine, Doha, Qatar, 3Q3 Research Institute (QRI), Research and Policy Division, Ypsilanti, MI, United States  \nMetronomic chemotherapy (MCT), characterized by the continuous administration of chemotherapeutics at a lower dose without prolonged drugfree periods, has garnered signiﬁcant attention over the last 2 decades. Extensive evidence from both pre-clinical and clinical settings indicates that MCT induces distinct biological effects than the standard Maximum Tolerated Dose (MTD) chemotherapy. The low toxicity proﬁle, reduced likelihood of inducing acquired therapeutic resistance, and low cost of MCT render it an attractive chemotherapeutic regimen option. One of the most prominent aspects of MCT is its anti-angiogenesis effects. It has been shown to stimulate the expression of anti-angiogenic molecules, thereby inhibiting angiogenesis. In addition, MCT has been shown to decrease the regulatory T-cell population and promote anti-tumor immune response through inducing dendritic cell maturation and increasing the number of cytotoxic T-cells. Combination therapies utilizing MCT along with oncolytic virotherapy, radiotherapy or other chemotherapeutic regimens have been studied extensively. This review providesan overview of the current status of MCT research and the established mechanisms of action of MCT treatment and also offers insights into potential avenues of development for MCT in the future.  \nKEYWORDS  \ncancer, metronomic chemotherapy, therapeutic resistance, combination therapy, photodynamic therapy  \n1 Metronomic chemotherapy: less is more  \nThe principle of chemotherapeutic drugs is to inhibit cell proliferation or induce cell death through many different mechanisms (Shewach and Kuchta, 2009) . The traditional regimen for chemotherapeutic administration has predominantly favored the Maximum Tolerated Dose (MTD) therapy approach for a long time (McConnell, 1989). MTD therapy utilizes the maximum dose that can be tolerated by the patient without inducing lethal consequences to the patient (Takimoto, 2009) . Though it is aimed at maximizing tumor depletion in the patient, the cytotoxic burden of this treatment option in normal tissues brings out the need for prolonged rest periods between administrations (Xu et al., 2021) . Side effects such as extensive damage to healthy tissues and neurotoxic properties","cbCaiaWO8JWwHEsZ","https://ap.wps.com/l/cbCaiaWO8JWwHEsZ","pdf",1395083,16,"English","# Metronomic chemotherapy: less is more\n## Principle of drug administration: MTD versus MCT\n## Historical context and rationale for regimen diversification","[{\"question\":\"What distinguishes metronomic chemotherapy (MCT) from Maximum Tolerated Dose (MTD) therapy?\",\"answer\":\"MCT uses continuous administration of chemotherapeutics at lower doses without prolonged drug-free periods, whereas MTD relies on the maximum dose tolerated without lethal harm, typically requiring rest intervals.\"},{\"question\":\"What main biological effects does MCT have according to the review?\",\"answer\":\"MCT is highlighted for anti-angiogenesis effects, stimulation of anti-angiogenic molecules, reduction of regulatory T-cell populations, and enhancement of anti-tumor immune responses through dendritic cell maturation and increased cytotoxic T-cells.\"},{\"question\":\"How does MCT relate to therapeutic resistance and treatment outcomes?\",\"answer\":\"The review notes that MCT has a reduced likelihood of inducing acquired therapeutic resistance, helping address relapse that can occur with standard MTD approaches.\"}]","Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy | PDF",1790041141,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41a8555890f289f9bb28d52fe2298e21.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1be4d3efeb4f6d1bfb8567359946a9b.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45baec6c69384981c463db44c88412de.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6cd66342a75aa964de9a8a6ee8bf23e2.webp",980,1385]